Ultimately, unraveling the function and regulation of FABP5 will allow us to identify new therapeutic targets for CS-mediated abnormal lung inflammation and airway injury in the pathogenesis of COPD. Here, FABP5 is linked to chronic obstructive pulmonary disease.